Contact
Hoe winkelen bij ons werkt
Bezorging
Winkelgids
mTOR Inhibition for Cancer Therapy: Past, Present and Future
Engels
219 b
Tot 30 dagen retourrecht
Klanten kochten ook
/
Gebonden (paperback)
60.21
€
/
Gebonden (paperback)
41.01
€
This book describes the challenges involved in developing mTOR inhibitors for cancer treatment, starting with an in-depth examination of their molecular mechanism of action, with emphasis on the class side-effects, efficacy and mechanisms of resistance, as well as on promising novel directions for their development, including novel compounds and rational combinations with other anti-neoplastic drugs. Over the last 10 years, inhibitors of mTOR have emerged as a major class of anticancer drugs. Two rapamycin analogs are currently approved for the treatment of renal cell carcinoma, and it is estimated that a variety of other tumor types could benefit from mTOR inhibition, with numerous clinical trials (including pivotal registration trials) already underway. Second-generation small-molecule inhibitors of the pathway have also shown promise in terms of their superior tolerability and efficacy and are undergoing extensive clinical evaluation, with an estimated 30+ compounds currently under evaluation.
Informatie over het boek
Engels
Categorieën
Geef dit boek vandaag nog cadeau
Dat gaat heel eenvoudig
1 Voeg het boek toe aan je winkelwagentje en selecteer Als cadeau bezorgen 2 Je krijgt van ons per omgaand een voucher 3 Het boek wordt bezorgd op het adres van de ontvangerDit vind je misschien ook interessant
/
Gebonden (paperback)
37.99
€
Hoi! Ik ben Libroamiko, je boekadviseur.
Hoe kan ik je helpen?